Go to the list of all blogs
Alicia's Avatar
published in Blogs
Apr 15, 2026
Why Is SolarEdge Technologies, Inc. (SEDG) Stock Down -12% Today?

Why Is SolarEdge Technologies, Inc. (SEDG) Stock Down -12% Today?

Key Takeaways

  • SolarEdge Technologies, Inc. (SEDG) shares are plunging 13.83% today, sliding from a prior close of $42.98 to around $37.04 in active midday trading.

  • The primary catalyst is a Goldman Sachs downgrade to Sell from Neutral, with the firm cutting its price target to $31 from $36 in a research note previewing Q1 2026 results and citing demand concerns.

  • Secondary pressure comes from Barclays' price target of $41 — now below yesterday's close — reinforcing a tightening analyst consensus even as the company's revenue recovery story remains intact.

  • Lingering sector-wide tariff concerns and competitive headwinds in the solar inverter market have weighed on the stock all month, with shares already dropping 7% on April 6 amid broader clean-energy selling.

  • Traders are now watching whether SEDG can hold support around the mid-$30s ahead of its Q1 2026 earnings release, with consensus projecting EPS of -$0.24 on revenue of $303.97 million.

Opening Summary

SolarEdge Technologies, Inc. (SEDG) designs and manufactures DC-optimized inverters, power optimizers, and energy storage solutions for residential and commercial solar energy systems, with products sold globally across the U.S., Europe, and Asia. Today, April 15, 2026, SEDG is down 13.83%, trading near $37.04 against a prior close of $42.98. This confirms a sharp downward move. The immediate driver is a Goldman Sachs downgrade to Sell coming ahead of quarterly earnings, amplified by recent tariff-related sector selling and a still-negative trailing P/E ratio that leaves the stock vulnerable to analyst-rating shifts.

Goldman Sachs Downgrade Drives Sentiment Shift

The single most direct trigger for today's sharp market reaction is Goldman Sachs' decision to downgrade SEDG from Neutral to Sell while cutting its 12-month price target from $36 to $31 — a level roughly 28% below yesterday's closing price. The downgrade was issued as part of a broader research note previewing Q1 2026 results, with the firm flagging concerns around near-term demand visibility in key markets and the pace of the company's margin recovery.

The downgrade carries weight given Goldman's reach and its timing ahead of a quarterly print where consensus already expects a per-share loss. With the company guiding Q1 2026 revenue of $290–320 million and non-GAAP gross margin of 20–24%, analysts are divided on whether the recovery trajectory is steep enough to justify the current premium over its deeply discounted 2024 lows. Goldman's move to Sell effectively signals that the risk-reward has deteriorated after SEDG's large year-to-date gains — up roughly 57% before today's decline and up over 200% over the trailing 12 months as recently as early April.

Tariff Concerns and Competitive Pressure

Today's Goldman-driven sell-off builds on a fragile backdrop. On April 6, SEDG already dropped 7% to around $45, alongside peer Enphase Energy (ENPH), which fell 4%, as broader tariff concerns weighed on solar inverter makers. Both companies face potential cost increases from proposed tariffs on imported components, while also battling intensifying competition from Chinese manufacturers offering lower-priced inverter alternatives in European and emerging markets.

SolarEdge's recovery has been real: full-year 2025 revenue reached $1.18 billion, up 31% year over year, with GAAP gross margin swinging from negative 97.3% in 2024 to positive 16.6% in 2025, and the company generating $76.9 million in free cash flow for the year. Nevertheless, the stock's elevated price relative to still-negative trailing earnings — a P/E ratio of approximately -6.25 — means the investment case is purely forward-looking, making it acutely sensitive to any analyst re-rating or guidance risk.

Market Context and Trading Activity

Volume today is significantly elevated: CNBC data show more than 4.6 million shares traded by late morning, already approaching or exceeding the stock's average daily volume of 3.17 million — confirming that institutional sellers are active, not just retail momentum players reacting to headlines. The intraday range has been wide, from a high of $45.10 at the open to a low of $41.41 before the stock broke further downward.

Technically, SEDG has now broken through the $40 support level that had held since the stock's sharp recovery rally began in late 2025. The 52-week range of $11.45–$53.75 shows just how extended the recovery had become. Broader market indices are mixed today, and clean-energy and solar ETFs are also under pressure, meaning SEDG's decline is both stock-specific (from the downgrade) and sector-driven (tariffs, competition).

Trending AI Robots

For traders navigating sharp analyst-driven moves in high-beta clean-energy stocks like SEDG, Tickeron's Trending AI Robots page highlights AI-driven trading bots that are currently performing best in live market conditions. Tickeron operates hundreds of algorithmic strategies across thousands of tickers, but only those with the strongest recent returns and risk-adjusted metrics are featured in this curated Trending section. These bots include momentum and breakout models designed to ride earnings-driven price rallies, as well as mean-reversion and volatility-focused strategies that look for entry points after steep declines like SEDG's 13.83% drop. Each bot discloses historical performance, drawdowns, holding periods, and traded symbols, enabling investors to match systematic strategies with their risk tolerance and time horizon. Active traders in SEDG can integrate these insights as a disciplined complement to fundamental and sector analysis.

What Comes Next for SEDG

The next major event for SEDG is its Q1 2026 earnings release, where consensus expects revenue of $303.97 million — implying 38.49% year-over-year growth — alongside an EPS loss of approximately $0.24. Investors will focus on whether the company hits the upper end of its $290–320 million revenue guidance, whether non-GAAP gross margins land toward the high end of the 20–24% range, and what management communicates about the trajectory toward GAAP profitability.

Longer-term, SEDG's path depends on several external factors: the outcome of tariff negotiations affecting solar component costs, competitive dynamics against lower-cost inverter manufacturers in Europe, and the pace of residential and commercial solar installations globally. The company's recent launch of U.S.-manufactured inverters from its Austin, Texas facility is a strategic hedge against tariff risk, but ramp-up takes time. Until profitability is restored and the competitive landscape stabilizes, SEDG is likely to remain volatile, with large moves around earnings, analyst actions, and energy-policy developments.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SEDG

Contributor

Alicia's AvatarAlicia|Beginner

SEDG sees its Stochastic Oscillator ascends from oversold territory

On October 05, 2026, the Stochastic Oscillator for SEDG moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In 54 of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SEDG just turned positive on October 05, 2026. Looking at past instances where SEDG's MACD turned positive, the stock continued to rise in 44 of 54 cases over the following month. The odds of a continued upward trend are 81%.

Following a +11.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where SEDG advanced for three days, in 220 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

SEDG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 106 of 138 cases where SEDG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SEDG as a result. In 78 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The 50-day moving average for SEDG moved below the 200-day moving average on September 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SEDG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. SEDG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.708) is normal, around the industry mean (4.934). P/E Ratio (95.917) is within average values for comparable stocks, (104.750). SEDG's Projected Growth (PEG Ratio) (4.609) is slightly higher than the industry average of (1.473). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (1.572) is also within normal values, averaging (5.257).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SEDG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

Notable companies

The most notable companies in this group are First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SolarEdge Technologies (NASDAQ:SEDG), Canadian Solar (NASDAQ:CSIQ).

Industry description

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

Market Cap

The average market capitalization across the Alternative Power Generation Industry is 1.91B. The market cap for tickers in the group ranges from 3.39K to 270.64B. CDVM holds the highest valuation in this group at 270.64B. The lowest valued company is MAXNQ at 3.39K.

High and low price notable news

The average weekly price growth across all stocks in the Alternative Power Generation Industry was 1%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -32%. SHLS experienced the highest price growth at 10%, while FTCI experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Alternative Power Generation Industry was -1%. For the same stocks of the Industry, the average monthly volume growth was -4% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 50
Price Growth Rating: 73
SMR Rating: 80
Profit Risk Rating: 98
Seasonality Score: 29 (-100 ... +100)
View a ticker or compare two or three
SEDG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of distributed solar power harvesting and photovoltaics monitoring solutions

Industry AlternativePowerGeneration

Industry
Semiconductors
Address
1 HaMada Street
Phone
+972 99576620
Employees
3576
Web
https://www.solaredge.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.